Table 1 Relationship between the expression of PD-L1 and CXCR3 and clinico-pathological characteristics of gastric cancer patients
From: CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
Clinico-pathological characteristics | Â | Number | CXCR3 expression | PD-L1 expression | ||||
|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Low(%) | High(%) | P value | Low(%) | High(%) | P value |
Age(years) | <60 | 42 | 31(73.8) | 11(26.2) | 0.343 | 20(47.6) | 22(52.4) | 0.675 |
≥60 | 50 | 41(82) | 9 (18) |  | 26(52) | 24(48) |  | |
Sex | Male | 72 | 60(83.3) | 12(16.7) | 0.025 | 38(52.8) | 34(47.2) | 0.312 |
Female | 20 | 12(60) | 8 (40) | Â | 8 (40) | 12(60) | Â | |
pTNM stage | I + II | 24 | 18(75) | 6 (25) | 0.652 | 7 (29.2) | 17(70.8) | 0.018 |
III + IV | 68 | 54(79.4) | 14(20.6) |  | 39(57.4) | 29(42.6) |  | |
N stage | Negtive | 23 | 17(73.9) | 6 (26.1) | 0.559 | 10(43.5) | 13(56.5) | 0.47 |
Positive | 69 | 55(79.7) | 14(20.3) | Â | 36(52.2) | 33(47.8) | Â | |
Lauren classification | Intestinal | 41 | 31(75.6) | 10(24.4) | 0.372 | 21(51.2) | 20(48.8) | 0.941 |
Diffuse | 44 | 34(77.3) | 10(22.7) | Â | 21(47.7) | 23(52.3) | Â | |
Mix | 7 | 7 (100) | 0 (0) | Â | 4 (57.1) | 3 (42.9) | Â | |